tiprankstipranks
Advertisement
Advertisement

Humana Shareholders Approve Directors, Auditor and Incentive Plan

Story Highlights
  • Humana shareholders re-elected all ten directors at the April 16, 2026 annual meeting, affirming continuity in the company’s board leadership.
  • Investors approved the 2026 auditor ratification, executive pay and stock incentive plan, while rejecting a proposal to tighten golden parachute oversight rules.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Humana Shareholders Approve Directors, Auditor and Incentive Plan

Claim 55% Off TipRanks

Humana ( (HUM) ) has provided an announcement.

At Humana Inc.’s regular annual meeting of stockholders held on April 16, 2026, shareholders elected all ten nominees to the board of directors, each to serve until the next annual meeting or until a successor is chosen. The voting showed broad support for the slate, with every director candidate receiving a clear majority of votes cast, reinforcing continuity in the company’s leadership and governance structure.

Shareholders also approved the ratification of PricewaterhouseCoopers LLP as Humana’s independent auditor for the year ending December 31, 2026, and backed on an advisory basis the company’s executive compensation program. In addition, investors approved the 2026 Stock Incentive Plan but voted down a shareholder proposal seeking a requirement for shareholder approval of excessive golden parachute arrangements, signaling confidence in existing pay and incentive practices while maintaining board flexibility on change-in-control compensation terms.

The most recent analyst rating on (HUM) stock is a Hold with a $173.00 price target. To see the full list of analyst forecasts on Humana stock, see the HUM Stock Forecast page.

Spark’s Take on HUM Stock

According to Spark, TipRanks’ AI Analyst, HUM is a Neutral.

The score is weighed down primarily by deteriorating profitability and a sharp 2025 cash-flow drop, reinforced by cautious 2026 earnings guidance driven by a sizable STARS headwind and margin pressure. Offsetting factors include improving near-term technical momentum and stable balance-sheet leverage, while valuation appears only moderately attractive given a ~26 P/E and modest dividend yield.

To see Spark’s full report on HUM stock, click here.

More about Humana

Humana Inc. is a U.S. health insurance and managed care company that offers medical and specialty health plans, with a focus on government-sponsored programs such as Medicare and Medicaid, as well as employer group and individual coverage. The company operates in the broader healthcare services and insurance industry, serving members, employers, and government payers nationwide.

Average Trading Volume: 2,217,560

Technical Sentiment Signal: Sell

Current Market Cap: $23.82B

See more insights into HUM stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1